A pulmonologist discusses the history and influence of race-based reference equations in pulmonary function testing interpretation and patient care.

Italy: A new cross-sectional study published in Respiratory Research has highlighted a significant association between vertebral fractures and impaired lung function in patients with ...

The FDA granted zongertinib Breakthrough Therapy Designation for patients with HER2 (ERBB2)-mutant advanced NSCLC as an initial treatment. The FDA also awarded a Commissioner's National Priority ...

This press release is not intended for UK mediaHERNEXEOS® (zongertinib tablets) approved based on an objective response rate of 76% (N=72) as ...

Live Science spoke with Dr. John Pandolfino, a researcher who designed a "digital twin" to help guide surgery.

This press release is not intended for UK media HERNEXEOS (zongertinib tablets) approved based on an objective response rate of 76% (N=72) as demonstrated in the Beamion LUNG-1 clinical trial1 Acceler ...

ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, ...

The BRAFTOVI combination regimen is the only approved targeted regimen for first-line BRAF-V600E mutant metastatic colorectal cancerPivotal results from the Phase 3 portion with mFOLFOX6 of the ...

We all have a concept of reality. We know what is “fact” and what isn’t. However, the truth of the matter is that the definition of “real” is a mere construct of the brain. If that didn’t blow your ...

'I’ve had to have my heart restarted once, twice, or more' ...

By the time cancer symptoms appear, the disease has already been developing for years, often leaving subtle clues in routine ...

Q4 2025 Earnings Call February 24, 2026 4:30 PM ESTCompany ParticipantsElizabeth Krutoholow - Vice President of Investor ...